
1. Neurol Neuroimmunol Neuroinflamm. 2020 Dec 15;8(1). pii: e929. doi:
10.1212/NXI.0000000000000929. Print 2021 Jan.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and
recovery patient 1: From the National Multiple Sclerosis Society Case Conference 
Proceedings.

Anadani N(1), Hyland M(1), Cruz RA(1), Lisak R(1), Costello K(1), Major EO(1),
Jassam Y(1), Meltzer E(1), Varkey TC(1), Parsons MS(1), Goodman AD(1), Graves
JS(1), Newsome S(1), Zamvil SS(1), Frohman EM(2), Frohman TC(2).

Author information: 
(1)From the University of Rochester (N.A.), NY. N. Anadani is now with Department
of Neurology, University of Oklahoma Health Science Center; Department of
Neurology (M.H., A.D.G.), University of Rochester, NY; Department of Neurology
(R.A.C., E.M., T.C.V.), Dell Medical School at the University of Texas at Austin;
Department of Neurology (R.L.), Wayne State University, Detroit, MI; The National
Multiple Sclerosis Society (K.C.), New York, NY; Laboratory of Molecular Medicine
and Neuroscience (E.O.M.), Neurological Institute of Neurological Disorder and
Stroke (Y.J.), Bethesda, MD. Y. Jassam is now with Department of Neurology, The
University of Kansas Health System; Colangelo College of Business (T.C.V.), Grand
Canyon University, Phoenix, AZ; Division of Microbiology and Immunology (M.S.P.),
Yerkes National Primate Research Center, and Department of Pathology and
Laboratory Medicine (M.S.P.), Emory University, Atlanta, GA; Department of
Neurosciences (J.S.G.), University of California at San Diego; Department of
Neurology (S.N.), Johns Hopkins University School of Medicine, Baltimore, MD;
Department of Neurology and Program in Immunology (S.S.Z.), University of
California San Francisco; and Department of Neurology, Neurosurgery, and
Ophthalmology (E.M.F., T.C.F.), Dell Medical School at the University of Texas at
Austin.
(2)From the University of Rochester (N.A.), NY. N. Anadani is now with Department
of Neurology, University of Oklahoma Health Science Center; Department of
Neurology (M.H., A.D.G.), University of Rochester, NY; Department of Neurology
(R.A.C., E.M., T.C.V.), Dell Medical School at the University of Texas at Austin;
Department of Neurology (R.L.), Wayne State University, Detroit, MI; The National
Multiple Sclerosis Society (K.C.), New York, NY; Laboratory of Molecular Medicine
and Neuroscience (E.O.M.), Neurological Institute of Neurological Disorder and
Stroke (Y.J.), Bethesda, MD. Y. Jassam is now with Department of Neurology, The
University of Kansas Health System; Colangelo College of Business (T.C.V.), Grand
Canyon University, Phoenix, AZ; Division of Microbiology and Immunology (M.S.P.),
Yerkes National Primate Research Center, and Department of Pathology and
Laboratory Medicine (M.S.P.), Emory University, Atlanta, GA; Department of
Neurosciences (J.S.G.), University of California at San Diego; Department of
Neurology (S.N.), Johns Hopkins University School of Medicine, Baltimore, MD;
Department of Neurology and Program in Immunology (S.S.Z.), University of
California San Francisco; and Department of Neurology, Neurosurgery, and
Ophthalmology (E.M.F., T.C.F.), Dell Medical School at the University of Texas at
Austin. Elliot.frohman@austin.utexas.edu.

DOI: 10.1212/NXI.0000000000000929 
PMCID: PMC7803340
PMID: 33411672 

